ArticleBMC cancer2018

Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study.

Tomonori Hirashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.